FDA Approves First Denosumab Biosimilar FDA Approves First Denosumab Biosimilar

Denosumab-bddz was also granted interchangeability status, which allows the biosimilar to subsitute for the reference product without involving the prescriber (according to state law).Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology Source Type: news